Emnar Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SODIUM BICARBONATE USP, with a corresponding US DMF Number 32436.
Remarkably, this DMF maintains an Active status since its submission on January 19, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 24, 2021, and payment made on May 17, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II